Fineline Cube

Follow:
14483 Articles
Shenzhen Chipscreen Biosciences Receives NMPA Approval for Chiauranib Clinical Study
CompanyDrug

Shenzhen Chipscreen Biosciences Receives NMPA Approval for Chiauranib Clinical Study

Innovent Biologics Halts Subscription Agreement with Lostrancos Ventures
CompanyDeals

Innovent Biologics Halts Subscription Agreement with Lostrancos Ventures

China's CDE Releases 88th Batch of Reference Preparations for Generic Drug Evaluation
Policy / Regulatory

China’s CDE Releases 88th Batch of Reference Preparations for Generic Drug Evaluation

AstraZeneca's China President Leon Wang Confirmed to Assist in Investigation Amid Fraud Allegations
Company

AstraZeneca’s China President Leon Wang Confirmed to Assist in Investigation Amid Fraud Allegations

Novartis' Trispecific Antibody PIT565 Secures NMPA Approval for Clinical Trial
CompanyDrug

Novartis’ Trispecific Antibody PIT565 Secures NMPA Approval for Clinical Trial

Chipscreen Biosciences' Tivozanib Secures NMPA Approval for ES-SCLC Phase III Trial
CompanyDrug

Shenzhen Chipscreen Biosciences’ Tivozanib Secures NMPA Approval for ES-SCLC Phase III Trial

Humanwell Healthcare Receives NMPA Approval for Compound Sodium Lactate Ringer's Injection
CompanyDrug

Humanwell Healthcare Receives NMPA Approval for Compound Sodium Lactate Ringer’s Injection

National Reimbursement Drug List (NRDL) Negotiations Conclude with Lower Generic Drug Approval Rate
Policy / Regulatory

National Reimbursement Drug List (NRDL) Negotiations Conclude with Lower Generic Drug Approval Rate

MSD Reports 4% YOY Revenue Increase in Q3 2024, Led by Pharmaceutical Sector
Company

MSD Reports 4% YOY Revenue Increase in Q3 2024, Led by Pharmaceutical Sector

Regeneron Pharmaceuticals Reports 11% YOY Revenue Growth in Q3 2024
Company

Regeneron Pharmaceuticals Reports 11% YOY Revenue Growth in Q3 2024

AbbVie Partners with EvolveImmune to Develop Immunotherapies for Cancer
CompanyDeals

AbbVie Partners with EvolveImmune to Develop Immunotherapies for Cancer

CARsgen Therapeutics' Suspended CAR-T Therapies Get FDA Green Light to Resume
CompanyDrug

CARsgen Therapeutics’ Suspended CAR-T Therapies Get FDA Green Light to Resume